Market Cap : 1.74 B | Enterprise Value : 1.58 B | PE Ratio : | PB Ratio : 19.08 |
---|
NAS:IMGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Immunogen's Total Stockholders Equity for the quarter that ended in Sep. 2020 was $-42.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.
Total Stockholders Equity is used to calculate Book Value per Share. Immunogen's Book Value per Share for the quarter that ended in Sep. 2020 was $-0.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Immunogen's Debt-to-Equity for the quarter that ended in Sep. 2020 was -0.58.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
1. Total Stockholders Equity is used to calculate Book Value per Share.
Immunogen's Book Value per Share for the quarter that ended in Sep. 2020 is
Book Value per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (-42.891 | - | 0) | / | 174.508 | |
= | -0.25 |
2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.
Immunogen's Debt-to-Equity for the quarter that ended in Sep. 2020 is
Debt-to-Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (5.264 | + | 19.403) | / | -42.891 | |
= | -0.58 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline